Abiopharma

Issa Mohamed Khairie 🔴 sold 19.1K shares of INCYTE CORP (INCY) at $109.07 ($2.1M) Transaction Date: Jan 06, 2026 | Filing ID: 000002

New Form S-3 - Flora Growth Corp. Filed: 2026-01-08 AccNo: 0001062993-26-000127 Size: 494 KB

(99% Neutral) PHATHOM PHARMACEUTICALS, INC. (PHAT) Announces Business Combination

Director Bassler Bonnie L 🟡 adjusted position in 1.5K shares (1 derivative) of REGENERON PHARMACEUTICALS, INC. (REGN) at $800.00 ($2.3M) Transaction Date: Jan 07, 2026 | Filing ID: 000008

Ware J. Anthony 🟢 acquired 9.5K shares (2 derivative) of ANAPTYSBIO, INC (ANAB) at $43.91 Transaction Date: Jan 06, 2026 | Filing ID: 000001

(90% Positive) PACIRA BIOSCIENCES, INC. (PCRX) Provides Update on leader for sustainable

Orwin John A 🟢 acquired 14.2K shares (2 derivative) of ANAPTYSBIO, INC (ANAB) at $43.91 Transaction Date: Jan 06, 2026 | Filing ID: 000001

New Form S-3 - Avalo Therapeutics, Inc. Filed: 2026-01-08 AccNo: 0001104659-26-002118 Size: 1 MB

New Form 424B5 - Phathom Pharmaceuticals, Inc. Filed: 2026-01-08 AccNo: 0001193125-26-007653 Size: 799 KB

(85% Positive) Anika Therapeutics, Inc. (ANIK) Announces Regulatory Update

Viridian Therapeutics, Inc. - Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Director Kauffman Michael 🟢 acquired 200.0K shares (1 derivative) of Verastem, Inc. (VSTM) at $6.88 ($1.4M) Transaction Date: Jan 06, 2026 | Filing ID: 002117

Inspira Technologies Oxy BHN (IINNW) Files Form 6-K

Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Revenues

Week 52 COACH Trial Topline Results Confirm Consistent and Durable Treatment Benefits in Children with Achondroplasia (ACH)